Carta científica
Insulinoma maligno avanzado. Respuesta y toxicidad con everolimus
Advanced malignant insulinoma. Everolimus response and toxicity
Leído
9414
Vecesse ha leído el artículo
1386
Total PDF
8028
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 10 | 9 | 19 |
| 2025 11 | 66 | 25 | 91 |
| 2025 10 | 77 | 12 | 89 |
| 2025 9 | 55 | 8 | 63 |
| 2025 8 | 53 | 8 | 61 |
| 2025 7 | 73 | 6 | 79 |
| 2025 6 | 93 | 9 | 102 |
| 2025 5 | 65 | 3 | 68 |
| 2025 4 | 64 | 6 | 70 |
| 2025 3 | 81 | 5 | 86 |
| 2025 2 | 69 | 5 | 74 |
| 2025 1 | 64 | 3 | 67 |
| 2024 12 | 61 | 6 | 67 |
| 2024 11 | 51 | 5 | 56 |
| 2024 10 | 48 | 7 | 55 |
| 2024 9 | 75 | 8 | 83 |
| 2024 8 | 62 | 9 | 71 |
| 2024 7 | 77 | 5 | 82 |
| 2024 6 | 55 | 12 | 67 |
| 2024 5 | 61 | 3 | 64 |
| 2024 4 | 59 | 1 | 60 |
| 2024 3 | 66 | 11 | 77 |
| 2024 2 | 85 | 9 | 94 |
| 2024 1 | 70 | 10 | 80 |
| 2023 12 | 81 | 5 | 86 |
| 2023 11 | 94 | 7 | 101 |
| 2023 10 | 103 | 18 | 121 |
| 2023 9 | 60 | 7 | 67 |
| 2023 8 | 67 | 10 | 77 |
| 2023 7 | 102 | 4 | 106 |
| 2023 6 | 82 | 8 | 90 |
| 2023 5 | 107 | 6 | 113 |
| 2023 4 | 85 | 3 | 88 |
| 2023 3 | 83 | 7 | 90 |
| 2023 2 | 70 | 8 | 78 |
| 2022 1 | 74 | 5 | 79 |
| 2022 12 | 69 | 9 | 78 |
| 2022 11 | 122 | 16 | 138 |
| 2022 10 | 70 | 15 | 85 |
| 2022 9 | 81 | 17 | 98 |
| 2022 8 | 70 | 12 | 82 |
| 2022 7 | 55 | 13 | 68 |
| 2022 6 | 95 | 8 | 103 |
| 2022 5 | 82 | 12 | 94 |
| 2022 4 | 53 | 7 | 60 |
| 2022 3 | 70 | 11 | 81 |
| 2022 2 | 91 | 9 | 100 |
| 2021 1 | 59 | 19 | 78 |
| 2021 12 | 75 | 30 | 105 |
| 2021 11 | 81 | 13 | 94 |
| 2021 10 | 109 | 24 | 133 |
| 2021 9 | 98 | 14 | 112 |
| 2021 8 | 70 | 6 | 76 |
| 2021 7 | 67 | 10 | 77 |
| 2021 6 | 58 | 12 | 70 |
| 2021 5 | 66 | 9 | 75 |
| 2021 4 | 174 | 32 | 206 |
| 2021 3 | 95 | 8 | 103 |
| 2021 2 | 76 | 10 | 86 |
| 2020 1 | 79 | 11 | 90 |
| 2020 12 | 85 | 16 | 101 |
| 2020 11 | 87 | 12 | 99 |
| 2020 10 | 81 | 8 | 89 |
| 2020 9 | 73 | 16 | 89 |
| 2020 8 | 86 | 18 | 104 |
| 2020 7 | 107 | 17 | 124 |
| 2020 6 | 79 | 14 | 93 |
| 2020 5 | 85 | 27 | 112 |
| 2020 4 | 85 | 8 | 93 |
| 2020 3 | 95 | 8 | 103 |
| 2020 2 | 108 | 12 | 120 |
| 2020 1 | 82 | 6 | 88 |
| 2019 12 | 142 | 14 | 156 |
| 2019 11 | 80 | 7 | 87 |
| 2019 10 | 76 | 9 | 85 |
| 2019 9 | 79 | 2 | 81 |
| 2019 8 | 56 | 13 | 69 |
| 2019 7 | 67 | 23 | 90 |
| 2019 6 | 130 | 39 | 169 |
| 2019 5 | 253 | 35 | 288 |
| 2019 4 | 126 | 36 | 162 |
| 2019 3 | 60 | 6 | 66 |
| 2019 2 | 44 | 14 | 58 |
| 2019 1 | 68 | 13 | 81 |
| 2018 12 | 47 | 7 | 54 |
| 2018 11 | 61 | 18 | 79 |
| 2018 10 | 100 | 11 | 111 |
| 2018 9 | 60 | 13 | 73 |
| 2018 8 | 28 | 11 | 39 |
| 2018 7 | 32 | 13 | 45 |
| 2018 6 | 57 | 5 | 62 |
| 2018 5 | 47 | 7 | 54 |
| 2018 4 | 24 | 7 | 31 |
| 2018 3 | 24 | 7 | 31 |
| 2018 2 | 13 | 4 | 17 |
| 2018 1 | 23 | 6 | 29 |
| 2017 12 | 5 | 3 | 8 |
| 2017 11 | 21 | 4 | 25 |
| 2017 10 | 27 | 4 | 31 |
| 2017 9 | 24 | 15 | 39 |
| 2017 8 | 31 | 1 | 32 |
| 2017 7 | 41 | 17 | 58 |
| 2017 6 | 31 | 15 | 46 |
| 2017 5 | 36 | 6 | 42 |
| 2017 4 | 34 | 4 | 38 |
| 2017 3 | 16 | 12 | 28 |
| 2017 2 | 18 | 12 | 30 |
| 2016 1 | 20 | 6 | 26 |
| 2016 12 | 29 | 13 | 42 |
| 2016 11 | 23 | 10 | 33 |
| 2016 10 | 49 | 12 | 61 |
| 2016 9 | 47 | 16 | 63 |
| 2016 8 | 31 | 12 | 43 |
| 2016 7 | 39 | 6 | 45 |
| 2016 6 | 30 | 15 | 45 |
| 2016 5 | 29 | 20 | 49 |
| 2016 4 | 18 | 17 | 35 |
| 2016 3 | 29 | 19 | 48 |
| 2016 2 | 21 | 11 | 32 |
| 2015 1 | 15 | 18 | 33 |
| 2015 12 | 19 | 8 | 27 |
| 2015 11 | 26 | 15 | 41 |
| 2015 9 | 0 | 1 | 1 |
| 2015 8 | 1 | 0 | 1 |
| 2015 5 | 1 | 0 | 1 |
| 2015 2 | 0 | 1 | 1 |
| 2014 12 | 0 | 1 | 1 |
| 2014 11 | 1 | 0 | 1 |
| 2014 9 | 1 | 0 | 1 |
| 2014 4 | 1 | 2 | 3 |
| 2014 3 | 22 | 0 | 22 |
| 2014 2 | 17 | 2 | 19 |
| 2014 1 | 12 | 6 | 18 |
Mostrar todo
